Feb 9, 2026 07:05AM
Feb 9, 2026 07:05AM
Jan 5, 2026 07:05AM
Jan 5, 2026 07:05AM
Dec 16, 2025 06:58AM
Dec 15, 2025 07:05AM
Dec 15, 2025 07:05AM Zenas BioPharma’s Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus
Nov 12, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 8, 2025 05:00AM
Oct 8, 2025 05:00AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
Sep 2, 2025 07:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All